Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza.

作者: Aditya H Gaur , Bindiya Bagga , Subrata Barman , Randall Hayden , Aubrey Lamptey

DOI: 10.1056/NEJMC0910893

关键词:

摘要: To the Editor: A 10-year-old girl with acute lymphoblastic leukemia was transferred to our hospital on August 31. The patient required mechanical ventilation for worsening lobar pneumonia, despite administration of broad-spectrum antibiotics (for details, see Supplementary Appendix, available full text this letter at NEJM.org). Two weeks earlier, she had completed 5 days oseltamivir an upper respiratory tract infection caused by influenza virus (with positive results rapid antigen testing). On 27, presented pneumonia negative admission hospital, . . .

参考文章(3)
David P. Calfee, Amy W. Peng, Lindsey M. Cass, Monica Lobo, Frederick G. Hayden, Safety and Efficacy of Intravenous Zanamivir in Preventing Experimental Human Influenza A Virus Infection Antimicrobial Agents and Chemotherapy. ,vol. 43, pp. 1616- 1620 ,(1999) , 10.1128/AAC.43.7.1616
Shawn Vasoo, Jane Stevens, Kamaljit Singh, Rapid Antigen Tests for Diagnosis of Pandemic (Swine) Influenza A/H1N1 Clinical Infectious Diseases. ,vol. 49, pp. 1090- 1093 ,(2009) , 10.1086/644743
I Michael Kidd, Jim Down, Eleni Nastouli, Rob Shulman, Paul R Grant, David CJ Howell, Mervyn Singer, H1N1 pneumonitis treated with intravenous zanamivir The Lancet. ,vol. 374, pp. 1036- 1036 ,(2009) , 10.1016/S0140-6736(09)61528-2